Sale!

AVPR2 Gene Nephrogenic Syndrome of Inappropriate Antidiuresis Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AVPR2 Gene Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect mutations in the AVPR2 gene. This gene is crucial for the normal function of the kidneys in managing water balance within the body. Mutations in the AVPR2 gene can lead to Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD), a rare condition characterized by the inability of the kidneys to properly concentrate urine in response to antidiuretic hormone, leading to water retention and hyponatremia (low sodium levels in the blood).

The test, priced at 4400 AED, involves analyzing the patient’s DNA to identify any genetic alterations in the AVPR2 gene that may be causing the syndrome. This is crucial for confirming the diagnosis, understanding the disease mechanism, and guiding treatment options. It is particularly recommended for individuals presenting symptoms of NSIAD, such as excessive thirst and urination, or for those with a family history of the condition. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test provides a reliable and accurate diagnosis, aiding clinicians in the management of NSIAD and improving patient outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis Genetic Test

Welcome to DNA Labs UAE, where we offer the AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis Genetic Test. This test is designed to diagnose and analyze the AVPR2 gene associated with nephrogenic syndrome of inappropriate antidiuresis (NSIAD), a rare genetic disorder.

Test Details

The AVPR2 gene is responsible for NSIAD, a condition characterized by excessive water reabsorption in the kidneys. This leads to an inability to properly regulate urine production, resulting in concentrated urine and potential complications such as low blood sodium levels (hyponatremia).

Our AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis Genetic Test utilizes Next-Generation Sequencing (NGS) technology to analyze the DNA sequence of genes, including the AVPR2 gene. This allows us to identify any mutations or abnormalities associated with NSIAD. By detecting specific mutations in the AVPR2 gene, we can confirm a diagnosis of NSIAD.

By identifying the genetic cause of NSIAD, our NGS genetic testing provides important information for patients and their families. This includes an accurate diagnosis, prognosis, and potential treatment options. Additionally, it can assist with genetic counseling and family planning decisions.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Hepatology, Nephrology, Endocrinology Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by NSIAD and the AVPR2 gene.

For more information or to schedule an appointment, please contact our genetics department.

Test Name AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis NGS Genetic DNA Test gene AVPR2
Test Details

The AVPR2 gene is associated with nephrogenic syndrome of inappropriate antidiuresis (NSIAD), which is a rare genetic disorder characterized by excessive water reabsorption in the kidneys. This condition leads to an inability to properly regulate urine production, resulting in excessive urine concentration and potential complications such as hyponatremia (low blood sodium levels).

NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to analyze the DNA sequence of genes, including the AVPR2 gene, to identify any mutations or abnormalities. This test can help confirm a diagnosis of NSIAD by detecting specific mutations in the AVPR2 gene that are known to be associated with the condition.

By identifying the genetic cause of NSIAD, NGS genetic testing can provide important information for patients and their families, including accurate diagnosis, prognosis, and potential treatment options. It can also help with genetic counseling and family planning decisions.